Digoxin
Product Images NDC 16714-590

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Digoxin (NDC 16714-590). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Digoxin 01)

Chemical structure of Digoxin, showing its characteristic steroid nucleus connected to a lactone ring and sugar moieties as represented in the diagram.*

FDA Label Image

Principal Display Panel 0.125mg (Digoxin 02)

Packaging label for Digoxin Tablets, USP 0.125 mg, containing 100 tablets. The label shows the NorthStar Rx LLC logo and states the product is manufactured by Sun Pharmaceutical Industries Ltd. in India. It includes storage instructions and packaging details such as dispensing information and a barcode.*

FDA Label Image

Principal Display Panel-0.25mg (Digoxin 03)

The packaging label for Digoxin Tablets, USP 0.25 mg shows a 100-tablet count. The label includes directions about dosage, pharmacist information for dispensing, and storage instructions. It lists Northstar Rx LLC as the labeler based in Memphis, TN, and Sun Pharmaceutical Industries Ltd. in Gujarat, India as the manufacturer. The label features a barcode and the NorthStar logo in blue and green colors.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.